However, there is an increasing trend toward using molecular testing to this end—for example, the Prediction Analysis of Microarray 50 (PAM50) and the Oncotype DX tests provide the risk of recurrence for breast cancer.
← all excerpts
Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis.
1
—
—